Aliphatic
amines are ubiquitously present in natural waters and
constitute one of the major moieties in dissolved organic matter and
water micropollutants such as pharmaceuticals. This paper presents
aliphatic amine {monomethylamine (CH3NH2, MMA),
dimethylamine [(CH3)2NH, DMA], and trimethylamine
[(CH3)3N, TMA]}-enhanced oxidation of pharmaceuticals
(trimethoprim, atenolol, carbamazepine, and sulfadiazine) by ferrate(VI)
[FeVIO4
2–, Fe(VI)]. The magnitude
of the enhancement varies with amines, and DMA shows the greatest
potential to increase the level of oxidation of trimethoprim. The
computational approach is applied to describe the trend of an increased
level of oxidation by Fe(VI) in the presence of amines. The computation
showed that an Fe(VI)/amine solution forms highly reactive FeIV species as intermediates that react with pharmaceuticals
to yield enhanced oxidation. In the rate-determining step of Fe(VI)
reactions with amines, TS1, the Fe(VI) is reduced and abstracts an
H from N, followed by the transfer of an O atom to N to form a very
stable intermediate involving a nitroxide radical. The abstracted
H is then transferred back to the N-O group in TS2 to form an H-bonded
product complex, which dissociates to the products. The difference
in the reactivity of the FeIV species with the type of
amine explains the trend seen experimentally in the enhanced oxidation
of pharmaceuticals.